Appointment

A round-up of the top senior appointments in the drug discovery sector over the last month. Renos Savva, Head of Innovation, Discovery Park Savva’s previous experience includes co-founding Domainex, recognised by the Financial Times in 2018 as the ‘fastest-growing drug discovery contract research organisation in Europe’, and developing and delivering the postgraduate Bio-business programme at […]

A round-up of the latest senior appointments in the drug discovery sector over the last month. Julian Collins, Jana Windt and Michiel Stork, ProBioGen Julian Collins has been appointed as Senior Vice President, Head of People & Organizational Development (P&OD) and a member of the Executive Team. Michiel Stork has taken on a role of Vice […]

The ABPI Board has confirmed that Susan Rienow, UK Country President of Pfizer, will be the next President of the Association of the British Pharmaceutical Industry (ABPI).   Rienow was appointed as ABPI Vice-President in September 2022 and will formally take up her role as President in May 2023.   As President, Rienow will lead the ABPI Board […]

There have been a number of significant appointments in the drug discovery sector over the last month. So who are the latest movers and shakers?  Amy Berrington and Montserrat Garcia-Closas, Institute of Cancer Research: Professors Amy Berrington and Montserrat Garcia-Closas have been appointed as Team Leaders at the Institute of Cancer Research’s Division of Genetics and […]

1. Antonin (Tony) de Fougerolles, Etherna  Antonin (Tony) de Fougerolles has joined the Etherna board of directors as an independent member.  He is currently the CEO of Evox Therapeutics. As founding Chief Scientific Officer (CSO) at Moderna Therapeutics, he pioneered modified mRNA.  2. Dr Xavier Jacq, Ubiquigent Ubiquigent has appointed Dr Xavier Jacq to its […]

News round-up by DDW Editor Reece Armstrong for 15-19 August. Covid booster approvals, positive results for Malaria vaccines and new CEOs are some of the stories in this week’s news round-up.  MHRA approves Moderna’s bivalent Covid booster   The Medicines and Healthcare products Regulatory Agency (MHRA) has approved an updated version of Moderna’s Covid-19 booster vaccine […]

Clinical-stage company Respira Technologies has appointed a new Chief Executive Officer (CEO) to the company.  Brian Quigley will take over as CEO after working as Respira’s Chief Operating Officer (COO) for the past two years.   Quigley previously worked at Altria Group for 16 years where he spent seven years as President & CEO at Altria’s […]

Biopharmaceutical company TikoMed has announced two new appointments to its Board of Directors as the company focuses on its ILB drug programme. TikoMed has appointed Tara Heitner and Pete Zorn to its Board of Directors. Tara Heitner has more than 15 years of experience in the biopharmaceutical industry and has been involved in the development […]

Techbio company Closed Loop Medicines has appointed two new members in support of its planned international growth.   Closed Loop Medicines appointed David Van Sickle as Non-Executive Director and Simon Ramsden as Chief Financial Officer.  Closed Loop Medicine says that the hires will help in the next stage of its growth as the company expands its […]

Biotechnology company Complement Therapeutics has appointed a new member to its board to help support the company with its development goals.   Complement Therapeutics appointed Steve Axon as in independent director to its Board of Directors who will help the company with its goals of addressing unmet needs in complement mediated diseases such as geographic atrophy due […]